<DOC>
	<DOC>NCT00902161</DOC>
	<brief_summary>This study will assess the effect of combined treatment with MK0893 plus propranolol versus placebo plus propranolol on hypoglycemia.</brief_summary>
	<brief_title>A Single-Dose Crossover Study of MK0893 in Patients With Type 2 Diabetes (0893-019 AM4)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<criteria>Participant has Type 2 Diabetes (T2DM) Participant is either: Not on an oral antihyperglycemic medication for at least 6 weeks; on a single oral antihyperglycemic medication that is not a peroxisome proliferatoractivated gamma (PPARgamma) agonist (e.g. Avandia); OR on a combination of no more than two antihyperglycemic medications that are not PPARgamma) agonists Participant has not received insulin for at least 6 months Participant has not been treated with a PPARgamma agonist for at least 12 weeks Participant has been a nonsmoker for at least 6 months Female participants who are nonpregnant and highly unlikely to conceive due to surgical sterilization, postmenopausal status, not heterosexually active, or willing to use 2 birth control methods Participant has a history of stroke, seizures, or neurological disorders Participant cannot tolerate insulin or propranolol Participant has a history of asthma, emphysema or chronic bronchitis Participant is on a weight loss program that is not in the maintenance phase or has been treated with a weight loss medication within 8 weeks of screening Participant is on or may require treatment with drugs that affect the immune system or with corticosteroids Participant has a history of heart failure or coronary artery disease Participant has a history of uncontrolled high blood pressure Participant is Human Immunodeficiency (HIV), hepatitis B or hepatitis C positive Participant has a history of Type 1 diabetes Participant has a history of hypoglycemia unawareness documented by a blood glucose concentration &lt; 55 mg/dL (3.1 mol/L) without symptoms of hypoglycemia.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>